July 24, 2013
Astellas Pharma announced on July 22 that its US-based subsidiary Astellas Pharma US received approval from the US FDA on July 19 for Astagraf XL (brand name in Japan: Graceptor), tacrolimus extended-release capsules, for the prophylaxis of organ rejection in...read more